Skip to content

    ELLEN

    ELLEN
    Chemicals·12 Nov 2025
    Management Summary

    Ellenbarrie Industrial Gases reported a strong Q2 FY26, with sequential revenue growth of 6.7% to ₹892 million and a significant 96% YoY increase in PAT to ₹367 million, driven by operational discipline and capital efficiency. The company maintained a stable EBITDA margin of 38% and saw its high-margin Argon business grow to 13% of revenues. While facing minor project execution delays, Ellenbarrie is actively expanding capacity and pursuing growth in specialty gases for emerging sectors like solar and semiconductors, targeting a 20-25% CAGR in core gases over the next 4-5 years.

    Highlights

    6
    • Revenue of ₹892 million, reflecting a 6.7% sequential increase.

    • EBITDA margin maintained at a stable 38% (₹337 million).

    • Profit After Tax (PAT) increased by 96% year-on-year to ₹367 million.

    • Successful ramp-up of operations at Kurnool and Tata Steel Metaliks plants, with Kurnool utilization now at 75-80%.

    • Argon, a high-margin gas, now contributes 13% to total revenues, up from 10% last quarter, with long-term bullish outlook.

    • New capacity additions expected to increase total owned and operated capacity to 1910 TPD by end of FY26 and over 2100 TPD by end of FY27.

    Concerns

    3
    • Project engineering revenues are lumpy, causing YoY revenue comparisons to be distorted without adjustment.

    • Small delays in project execution for new plants, pushing some commissioning timelines by a month or a half-year.

    • Short-term fluctuations in Argon prices are possible, although long-term outlook remains bullish and sales are protected by contracts.

    Key financials

    Single quarter

    04 metrics
    1. 01Revenue892 Mn+6.7%QoQ
    2. 02EBITDA337 Mn
    3. 03EBITDA Margin38%
    4. 04PAT367 Mn+96%YoY

    Capital allocation

    1
    medium confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Guidance & targets

    8
    CategoryTargetPriority
    Revenue Growth (Core Gases)
    Revenue CAGR
    20 to 25%
    High
    Profitability
    EBITDA Margin
    around 40%
    High
    Capacity
    Total Owned and Operated Capacity
    1910 tons per day
    High
    Capacity
    Total Owned and Operated Capacity
    over 2100 tons per day
    High
    Argon Contribution
    Argon Revenue Contribution
    inch up
    Medium
    Argon Profitability
    Argon EBITDA Margin
    higher than 40%
    Medium
    Traded Specialty Gases Profitability
    Traded Products Margin
    15 to 20%
    Medium
    220 TPD Plant Revenue Potential
    Annual Revenue
    100 plus crores
    High

    East India Merchant Plant Commissioning

    next quarter
    CurrentExpected end of November 2025 (delayed by ~1 month)
    TargetCommercial operations commenced

    Why it matters

    This new capacity is expected to ramp up quickly and contribute significantly to H2 FY26 revenues, supporting overall growth targets.

    Our merchant plant in East India is on track to go live end of this month. So, there's been about a delay of a month or so.

    How to verify

    detailed_narrative

    Risks & concerns

    3
    RiskSeverity

    Project Execution Delays

    Delays of about a month for East India merchant plant and pushing next merchant plant from Q2 FY27 to H2 FY27. Management views this as a key risk for growing businesses in the sector.Management acknowledged

    medium

    Short-term Argon Price Fluctuations

    While long-term demand for Argon is strong and bullish, short-term prices may fluctuate. However, sales are largely protected by long-term contracts, mitigating significant impact.Management acknowledged

    low

    Lumpy Project Engineering Revenue

    Project engineering revenue is not consistent quarter-on-quarter, which can distort overall revenue comparisons. Management emphasizes focusing on the core gases business for consistent growth.Management acknowledged

    low

    Q&A highlights

    8

    “While there is no change in the GST on industrial gases, but for products such as medical oxygen, the GST has actually been reduced from 12% to 5%.”

    Clarifies regulatory impact, showing a positive change for medical oxygen, which is a critical product for the company.

    asked by Ashok Mithinthi

    3 min read6 chapters

    Detailed Narrative

    01

    Q2 FY26 Performance Overview

    Ellenbarrie Industrial Gases reported Q2 FY26 revenues of ₹892 million, marking a 6.7% sequential increase. The company maintained a stable EBITDA margin of 38%, translating to ₹337 million. Profit After Tax (PAT) saw a significant 96% year-on-year surge, reaching ₹367 million, reflecting strong operational discipline and capital efficiency. The core gases business continues to be the primary growth driver, with management emphasizing its resilience and contribution to overall performance.

    02

    Capacity Expansion and Project Timelines

    The company successfully ramped up operations at its Kurnool and Tata Steel Metaliks plants, with Kurnool's utilization now at 75-80% from 60-65% in Q1. A new merchant plant in East India and a 220 TPD plant are expected to commence production by the end of November 2025. The onsite plant in East India is slated for commissioning by March 2026, while another merchant plant has been pushed from Q2 FY27 to H2 FY27 due to minor execution delays. These expansions will increase total owned and operated capacity to 1910 TPD by end of FY26 and over 2100 TPD by end of FY27.

    03

    Strategic Focus: Argon and Specialty Gases

    Argon, a high-margin value-added gas, now accounts for 13% of total revenues, up from 10% last quarter, with management expecting this contribution to 'inch up' long-term and its EBITDA margins to be 'higher than 40%.' The company is also actively targeting the solar cell and semiconductor sectors with ultra-high purity gases like nitrogen, oxygen, silane, ammonia, and nitrous oxide. For traded specialty products, margins are anticipated to be in the 15-20% range, and the company has already secured 3 contracts in this space with phenomenal inquiry levels.

    04

    GST Impact and Revenue Guidance Clarification

    The government's decision to reduce GST on medical oxygen from 12% to 5% was welcomed, making the critical product more affordable. Management clarified its revenue guidance of 20-25% CAGR applies specifically to the core gases business over the next four to five years, using the last full financial year as a base. This distinction is crucial as project engineering revenues are lumpy and can distort overall year-on-year comparisons, which showed a 10% growth in core gases after adjusting for last year's project engineering revenue of ₹150 million.

    05

    Geographical Expansion and Market Penetration

    Ellenbarrie is actively pursuing geographical expansion to become a pan-India company, with a strong focus on Western, Central, and North India, where it historically had less presence. While a site for a new merchant plant in Western India has been largely finalized, an official announcement is pending. The strategy for penetrating new markets with existing vendors involves leveraging efficient cost of production, existing customer relationships with multi-location operations, and the overall expanding market size, ensuring growth capture across regions.

    06

    Hydrogen Electrolyzer Initiative

    The company's hydrogen electrolyzer pilot is progressing, with plans to integrate this technology into future air separation plants. However, management emphasized that hydrogen is viewed as another gas in their portfolio, primarily for industrial customers like pharmaceutical and edible oil companies, rather than as a significant energy resource. It is not expected to be a meaningful contributor to overall revenue, which will continue to be driven by air separation gases.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.